Elarofiban Hydrate is a nonpeptide glycoprotein IIb/IIIa (GPIIb/IIIa) antagonist utilized in the prevention of ischemic events for patients undergoing percutaneous coronary intervention. As a potent antiplatelet… Read more
Elarofiban Hydrate is a nonpeptide glycoprotein IIb/IIIa (GPIIb/IIIa) antagonist utilized in the prevention of ischemic events for patients undergoing percutaneous coronary intervention. As a potent antiplatelet agent, this compound inhibits platelet aggregation induced by various agonists, including thrombin, collagen, and ADP. This category provides essential reference standards, impurities, metabolites, and stable isotope labelled compounds required for the rigorous quality control and analytical testing of the drug. Pharmaceutical laboratories rely on these high-quality materials for impurity profiling, method validation, and structural characterization throughout the drug development lifecycle. By utilizing accurate isotope-labelled standards and analytical reference materials, researchers can ensure compliance with regulatory guidelines and maintain the precision of their assays during the assessment of this medication and its related derivatives.